Does Rallies show Form 4 insider transactions for ATHA?

Yes. Rallies tracks ATHA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is ATHA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ATHA. It does not provide personalized investment advice.

ATHA (Athira Pharma, Inc. Common Stock) Stock Analysis - Insider Trades

Athira Pharma, Inc. Common Stock (ATHA) is a publicly traded Healthcare sector company. As of May 21, 2026, ATHA trades at $6.75 with a market cap of $26.62M and a P/E ratio of -0.27. ATHA moved -7.53% today. Year to date, ATHA is +1566.67%; over the trailing twelve months it is +1042.91%. Its 52-week range spans $0.22 to $8.36. Analyst consensus is hold with an average price target of $13.33. Rallies surfaces ATHA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading ATHA stock inside the company?

Recent ATHA insider activity includes San Martin Javier sold 1.64K, Litton Mark James sold 2.59K, Renninger Robert sold 297, CHURCH KEVIN sold 876, and Worthington Mark sold 876. Rallies tracks insider transaction dates, shares, prices, and estimated values.

ATHA Key Metrics

Key financial metrics for ATHA
Metric	Value
Price	$6.75
Market Cap	$26.62M
P/E Ratio	-0.27
EPS	$-24.70
Dividend Yield	0.00%
52-Week High	$8.36
52-Week Low	$0.22
Volume	70.26K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-105.61M
Gross Margin	0.00%

Recent ATHA Insider Trades

San Martin Javier sold 1.64K (~$11.31K) on Jan 2, 2026.
Litton Mark James sold 2.59K (~$17.79K) on Jan 2, 2026.
Renninger Robert sold 297 (~$2.04K) on Jan 2, 2026.
CHURCH KEVIN sold 876 (~$6.03K) on Jan 2, 2026.
Worthington Mark sold 876 (~$6.03K) on Jan 2, 2026.

Latest ATHA News

ATHA Energy Secures US$20M Five-Year Debenture with 12% Coupon Convertible at C$0.85 — Jan 13, 2026
ATHA Energy Secures US$20M Convertible Debenture Financing at 12% Coupon — Jan 13, 2026

ATHA Analyst Consensus

5 analysts cover ATHA: 0 strong buy, 0 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is hold. Average price target: $13.33.

Common questions about ATHA

Who is trading ATHA stock inside the company?: Recent ATHA insider activity includes San Martin Javier sold 1.64K, Litton Mark James sold 2.59K, Renninger Robert sold 297, CHURCH KEVIN sold 876, and Worthington Mark sold 876. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ATHA?: Yes. Rallies tracks ATHA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ATHA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ATHA. It does not provide personalized investment advice.